AU2002364456A1 - Use of compounds of the benzamide family as immunosuppressant - Google Patents

Use of compounds of the benzamide family as immunosuppressant

Info

Publication number
AU2002364456A1
AU2002364456A1 AU2002364456A AU2002364456A AU2002364456A1 AU 2002364456 A1 AU2002364456 A1 AU 2002364456A1 AU 2002364456 A AU2002364456 A AU 2002364456A AU 2002364456 A AU2002364456 A AU 2002364456A AU 2002364456 A1 AU2002364456 A1 AU 2002364456A1
Authority
AU
Australia
Prior art keywords
immunosuppressant
compounds
benzamide
family
benzamide family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002364456A
Other versions
AU2002364456A8 (en
Inventor
Delphine Carbonnelle
Francois Lang
Jean-Yves Petit
Jean-Michel Robert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Nantes
Original Assignee
Universite de Nantes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Nantes filed Critical Universite de Nantes
Publication of AU2002364456A1 publication Critical patent/AU2002364456A1/en
Publication of AU2002364456A8 publication Critical patent/AU2002364456A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002364456A 2001-12-19 2002-12-18 Use of compounds of the benzamide family as immunosuppressant Abandoned AU2002364456A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0116443A FR2833494B1 (en) 2001-12-19 2001-12-19 USE OF BENZAMIDE FAMILY COMPOUNDS AS IMMUNOSUPPRESSANT AGENT
FR01/16443 2001-12-19
PCT/FR2002/004415 WO2003051365A2 (en) 2001-12-19 2002-12-18 Use of compounds of the benzamide family as immunosuppressant

Publications (2)

Publication Number Publication Date
AU2002364456A1 true AU2002364456A1 (en) 2003-06-30
AU2002364456A8 AU2002364456A8 (en) 2003-06-30

Family

ID=8870680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364456A Abandoned AU2002364456A1 (en) 2001-12-19 2002-12-18 Use of compounds of the benzamide family as immunosuppressant

Country Status (3)

Country Link
AU (1) AU2002364456A1 (en)
FR (1) FR2833494B1 (en)
WO (1) WO2003051365A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0784462B2 (en) * 1986-07-25 1995-09-13 日清製粉株式会社 Benzimidazole derivative
FR2707085B1 (en) * 1993-06-30 1995-08-18 Adir New alpha amino acid derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2720396B1 (en) * 1994-05-27 1996-06-28 Adir New N-pyridyl carboxamides and derivatives, their preparation process and the pharmaceutical compositions containing them.

Also Published As

Publication number Publication date
FR2833494B1 (en) 2006-12-15
WO2003051365A3 (en) 2004-03-04
FR2833494A1 (en) 2003-06-20
WO2003051365A2 (en) 2003-06-26
WO2003051365A9 (en) 2004-05-06
AU2002364456A8 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
AU2001262475A1 (en) Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
AU2002360375A1 (en) Synthesis strategies based on the appropriate use of inductance effects
AU2002255918A1 (en) Human serine/threonine kinase
AU2002314044A1 (en) Novel use of 2-phenyl-substituted imidazotriazinones
AU2002230098A1 (en) Heterocyclic compounds and cognitive enhancers comprising the same as effective components
AU2003206367A1 (en) Technical field of the invention
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2002343100A1 (en) The use of metal-chelating adsorbents
AU2002364456A1 (en) Use of compounds of the benzamide family as immunosuppressant
AU2002251543A1 (en) Novel atisane compound and use thereof
AU2003238034A1 (en) Novel use of imidazotriazinones
EP1238585B8 (en) Use of esterquats
AU2002361989A1 (en) N,n'-disubstituted piperazine compounds and the use of the same as analgesics
AU2003248597A1 (en) The purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
AU2002331162A1 (en) Human serine/threonine kinase
AUPR666601A0 (en) Benzamide compounds
AU2002247289A1 (en) Human grk7: new member of the human g-protein-coupled-receptor kinase family
TW573751U (en) Structure capable of preventing jaming
AU2002256760A1 (en) Novel compounds of the family of 3-alkyl-(4,5 diphenyl-imidazol-1-yl) and their use as soothing agents
AU2002313591A1 (en) New use of cyclic compounds
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002313019A1 (en) Compounds of the family of 3-alkyl-(4,5 dipheny-imidazol-1-yl) and their use as soothing agents
AU2001288046A1 (en) Novel use of tricyclic compound
AU2002338934A1 (en) Preparation of benzosuberonylpiperidine compounds
AU2002331285A1 (en) Use of 1,1,1,3,3-pentafluorobutan

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase